Sign inGet started

Trigilio Jeffrey

Insider CIK 1838671 · CGEM Chief Financial Officer · XOMA Chief Financial Officer

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
XOMA XOMA Royalty Corp D To issuer deriv2026-07-142026-07-1426,000— $00SEC↗
XOMA XOMA Royalty Corp D To issuer deriv2026-07-142026-07-14126,924— $00SEC↗
XOMA XOMA Royalty Corp J Other2026-07-142026-07-14103,906— $00SEC↗
XOMA XOMA Royalty Corp M Exercise deriv2026-04-202026-04-2211,538— $0126,924SEC↗
XOMA XOMA Royalty Corp M Exercise2026-04-202026-04-2211,538— $0103,906SEC↗
XOMA XOMA Royalty Corp M Exercise deriv2026-04-132026-04-154,000— $026,000SEC↗
XOMA XOMA Royalty Corp M Exercise2026-04-132026-04-154,000— $094,000SEC↗
XOMA XOMA Royalty Corp F Tax w/h2026-04-132026-04-151,632$36.76 $60.0K92,368SEC↗
XOMA XOMA Royalty Corp A Award deriv2026-03-112026-03-13138,462— $0138,462SEC↗
XOMA XOMA Royalty Corp A Award2026-03-112026-03-1390,000— $090,000SEC↗
XOMA XOMA Royalty Corp A Award deriv2026-01-122026-01-1430,000— $030,000SEC↗
CGEM Cullinan Oncology, Inc. A Award deriv2024-02-222024-02-23100,000— $0100,000SEC↗
CGEM Cullinan Oncology, Inc. A Award2024-02-222024-02-2350,000— $0133,919SEC↗
CGEM Cullinan Oncology, Inc. S Sale2023-12-212023-12-221,920$8.50 $16.3K83,919SEC↗
CGEM Cullinan Oncology, Inc. S Sale2023-12-182023-12-20398$8.22 $3.3K85,839SEC↗
CGEM Cullinan Oncology, Inc. S Sale2023-12-122023-12-131,926$7.81 $15.0K86,237SEC↗
CGEM Cullinan Oncology, Inc. A Award2023-06-302023-07-052,340$9.08 $21.2K88,163SEC↗
CGEM Cullinan Oncology, Inc. S Sale2023-06-202023-06-21399$12.94 $5.2K85,823SEC↗
CGEM Cullinan Oncology, Inc. S Sale2023-06-122023-06-14319$13.11 $4.2K86,222SEC↗
CGEM Cullinan Oncology, Inc. S Sale2023-05-182023-05-19399$8.76 $3.5K86,541SEC↗
CGEM Cullinan Oncology, Inc. S Sale2023-05-122023-05-16347$8.78 $3.0K86,940SEC↗
CGEM Cullinan Oncology, Inc. S Sale2023-04-182023-04-20398$10.71 $4.3K87,287SEC↗
CGEM Cullinan Oncology, Inc. S Sale2023-04-122023-04-14318$10.22 $3.2K87,685SEC↗
CGEM Cullinan Oncology, Inc. S Sale2023-03-202023-03-27399$11.32 $4.5K88,003SEC↗
CGEM Cullinan Oncology, Inc. A Award deriv2023-02-172023-02-2193,500— $093,500SEC↗
CGEM Cullinan Oncology, Inc. A Award2023-02-172023-02-2147,000— $088,402SEC↗
CGEM Cullinan Oncology, Inc. A Award2022-12-302023-01-06201$8.97 $1.8K41,402SEC↗
CGEM Cullinan Oncology, Inc. A Award2022-06-302022-07-051,451$10.90 $15.8K41,201SEC↗
CGEM Cullinan Oncology, Inc. A Award deriv2022-02-112022-02-1575,000— $075,000SEC↗
CGEM Cullinan Oncology, Inc. A Award2022-02-112022-02-1537,500— $039,750SEC↗
CGEM Cullinan Oncology, Inc. M Exercise deriv2021-10-152021-10-188,000— $0229,891SEC↗
CGEM Cullinan Oncology, Inc. M Exercise2021-10-152021-10-188,000$4.30 $34.4K10,250SEC↗
CGEM Cullinan Oncology, Inc. S Sale2021-10-152021-10-188,000$25.00 $200.0K2,250SEC↗
CGEM Cullinan Oncology, Inc. M Exercise deriv2021-09-082021-09-0915,000— $0237,891SEC↗
CGEM Cullinan Oncology, Inc. S Sale2021-09-082021-09-095,487$27.83 $152.7K11,763SEC↗
CGEM Cullinan Oncology, Inc. S Sale2021-09-082021-09-099,513$28.85 $274.5K2,250SEC↗
CGEM Cullinan Oncology, Inc. M Exercise2021-09-082021-09-0915,000$4.30 $64.5K17,250SEC↗
CGEM Cullinan Management, Inc. P Buy2021-01-122021-01-142,250$21.00 $47.3K2,250SEC↗
CGEM Cullinan Management, Inc. A Award deriv2021-01-072021-01-11146,665— $0146,665SEC↗